Long-term mood stabilizer use in bipolar disorder Mixed and psychotic features and comorbid anxiety disorder were also associated with poor treatment response. About one-third of patients receiving ...

ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for ...

Source: Francesco Mocellin / Used with permission Interest in lithium has been renewed in recent years, not only as a classic mood stabilizer for bipolar illness but also as a potential low-dose ...

From recent research on trauma to advances in genetics, here are 5 new developments in the world of bipolar disorder. While everyone’s journey with bipolar disorder is individual, no one has to travel ...

Researchers from the University of Adelaide are hopeful a recent biological discovery could lead to the precision treatment of bipolar disorder (BD). About 2.2% of the Australian population has a form ...

Harvard University Associate Professor, Dr. Ovidiu Andronesi MD, PhD, will be the principal investigator of the study Head-to-head study of AL001 versus a marketed lithium carbonate product will be ...

A second meta-analysis of antimanic treatments, conducted by Yildiz et al, 6 focused on direct comparisons of individual medications and on effects of classes of medication. Second-generation ...